Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...

Shares of Palatin Technologies, Inc. (PTN) gained 16% on Monday after the company announces completion of patient enrollment in phase ...

KEY POINTS A 72-year-old man presented to the emergency department with a 2-week history of hypotension, postural dizziness, and muscle weakness. He had a medical history of HIV, lipodystrophy, ...

Doron Therapeutics, a clinical-stage biotech company focusing on degenerative musculoskeletal conditions, today announced it has successfully raised an aggregate $11 million as an initial Series A ...

A young teacher who suffers from severe asthma has spoken of how patients with the high-risk condition can be left on ...

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ...

Low anti-TNF levels during infliximab or adalimumab maintenance treatment are linked to increased risk for treatment failure in pediatric CD.

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and ...

And as astute pet parents, we usually have a good idea of what these sounds mean: feed me, pet me, please let me in. But would you recognize the sound of a cat wheezing? If the answer is no, don’t ...

There are several factors that can increase the risk of developing osteoporosis, such as prolonged use of high-dose steroids or anti-epileptic medicines ... such as weekly oral tablets (alendronate, ...